Who owns Global X - Genomics & Biotechnology ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GNOM from SEC Form 13F filings across 48 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 48 institutions disclosed 482,018 shares of Global X - Genomics & Biotechnology ETF worth $27.4M — about 32.9% of shares outstanding; the largest disclosed holder is BANK OF AMERICA CORP /DE/. Source: SEC Form 13F filings, parsed by EvidInvest.
48
13F holders
$27.4M
value, 2026 filers
32.9%
of shares outstanding (482,018 sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GNOM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 112,874 | $6.4M | 0.0% | 7.7% | -5.8% |
| 2 | Sumitomo Mitsui Trust Group, Inc.NEW | 93,103 | $5.3M | 0.0% | 6.4% | new |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 40,763 | $2.3M | 0.0% | 2.8% | +121.9% |
| 4 | LPL Financial LLC | 37,599 | $2.1M | 0.0% | 2.6% | +38.4% |
| 5 | OPPENHEIMER ASSET MANAGEMENT INC. | 17,449 | $991,694 | 0.0% | 1.2% | -0.5% |
| 6 | Arax Advisory PartnersNEW | 16,270 | $924,689 | 0.0% | 1.1% | new |
| 7 | Stratos Wealth Partners, LTD. | 14,645 | $832,334 | 0.0% | 1% | +0.2% |
| 8 | CREATIVE FINANCIAL DESIGNS INC /ADV | 11,892 | $675,870 | 0.0% | 0.8% | +12.6% |
| 9 | JANE STREET GROUP, LLC | 11,522 | $654,841 | 0.0% | 0.8% | -28.2% |
| 10 | Foundations Investment Advisors, LLCNEW | 11,000 | $625,174 | 0.0% | 0.8% | new |
| 11 | SLT Holdings LLCNEW | 11,000 | $625,174 | 0.4% | 0.8% | new |
| 12 | Wealth Management Partners, LLC | 10,144 | $576,524 | 0.1% | 0.7% | +81.6% |
| 13 | UBS Group AG | 9,603 | $545,777 | 0.0% | 0.7% | -9.6% |
| 14 | Sightline Wealth Advisors, LLC | 9,502 | $540,019 | 0.2% | 0.6% | -1.9% |
| 15 | Belvedere Trading LLCNEW | 8,626 | $490,250 | 0.0% | 0.6% | new |
| 16 | RAYMOND JAMES FINANCIAL INC | 8,515 | $483,942 | 0.0% | 0.6% | -8.5% |
| 17 | Bison Wealth, LLC | 8,313 | $489,033 | 0.0% | 0.6% | -38.1% |
| 18 | Gladstone Institutional Advisory LLCNEW | 8,102 | $460,469 | 0.0% | 0.6% | new |
| 19 | CITADEL ADVISORS LLC | 6,179 | $351,177 | 0.0% | 0.4% | 0.0% |
| 20 | Comprehensive Money Management Services LLC | 5,266 | $299,288 | 0.2% | 0.4% | 0.0% |
| 21 | J.W. COLE ADVISORS, INC.NEW | 4,829 | $274,435 | 0.0% | 0.3% | new |
| 22 | Manhattan West Asset Management, LLCNEW | 4,252 | $241,658 | 0.0% | 0.3% | new |
| 23 | CENTAURUS FINANCIAL, INC. | 4,186 | $238,000 | 0.0% | 0.3% | +3.3% |
| 24 | SIMPLEX TRADING, LLCNEW | 3,477 | $197,611 | 0.0% | 0.2% | new |
| 25 | Rockefeller Capital Management L.P. | 3,107 | $176,632 | 0.0% | 0.2% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.